Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
urinary incontinence
MedTech
Urinary incontinence neuromod newcomer Amber nets $100M
The University of Oxford spinout's series A round follows up on positive preliminary data from a first-in-human trial earlier this year.
Conor Hale
Jun 10, 2024 4:40pm
BlueWind nabs de novo nod for incontinence neuromod system
Aug 17, 2023 10:22am
Renovia's digital exercise app cleared for fecal incontinence
Jul 11, 2022 8:51am
BlueWind breezes into $64M for overactive bladder implant
May 10, 2022 10:30am
Axonics kicks off U.S. launch of recharge-free neurostim implant
Apr 19, 2022 10:20am
Axonics trails Medtronic with FDA OK for sacral neurostim system
Mar 8, 2022 11:18am
